1. Home
  2. MQ vs HRMY Comparison

MQ vs HRMY Comparison

Compare MQ & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marqeta Inc.

MQ

Marqeta Inc.

HOLD

Current Price

$15.96

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$38.41

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MQ
HRMY
Founded
2010
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.2B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
MQ
HRMY
Price
$15.96
$38.41
Analyst Decision
Hold
Buy
Analyst Count
10
9
Target Price
$5.36
$44.11
AVG Volume (30 Days)
1.2M
890.3K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.97
EPS
N/A
1.84
Revenue
$624,884,000.00
$868,453,000.00
Revenue This Year
$16.89
$19.75
Revenue Next Year
$16.36
$12.88
P/E Ratio
N/A
$21.06
Revenue Growth
23.25
21.51
52 Week Low
$3.70
$25.52
52 Week High
$18.69
$40.87

Technical Indicators

Market Signals
Indicator
MQ
HRMY
Relative Strength Index (RSI) 60.13 63.35
Support Level $16.52 $37.12
Resistance Level $17.79 $39.07
Average True Range (ATR) 0.72 1.60
MACD -0.53 0.28
Stochastic Oscillator 14.16 82.13

Price Performance

Historical Comparison
MQ
HRMY

About MQ Marqeta Inc.

Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: